# AstraZeneca net income entity: /record/astrazeneca.md predicate: net_income page: /record/astrazeneca/net_income as_of: 2026-11-08 cite: AsOf. "AstraZeneca net income: 10,233,000,000 United States dollar", as of 2025-12-31. Claim clm_7F0BFE9EB1CD, https://asof.is/claim/clm_7F0BFE9EB1CD, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm. As of November 8, 2026, AstraZeneca's net income on the AsOf record is $10.23 billion, dated December 31, 2025, from a primary source (sec.gov). 11 claims on AstraZeneca's net income, 1 open and 10 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Current net income What the record asserts on 2026-11-08. - [AstraZeneca](/record/astrazeneca.md) | net_income | 10,233,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7F0BFE9EB1CD](/claim/clm_7F0BFE9EB1CD.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [AstraZeneca](/record/astrazeneca.md) | net_income | 2,826,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_194B34501880](/claim/clm_194B34501880.md) | [clm_DEF1603E885B](/claim/clm_DEF1603E885B.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 3,406,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_7BDCCD2AEF61](/claim/clm_7BDCCD2AEF61.md) | [clm_194B34501880](/claim/clm_194B34501880.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 2,868,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_80CF1A157103](/claim/clm_80CF1A157103.md) | [clm_7BDCCD2AEF61](/claim/clm_7BDCCD2AEF61.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 2,050,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_529E4815C0D2](/claim/clm_529E4815C0D2.md) | [clm_80CF1A157103](/claim/clm_80CF1A157103.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465919012881/0001104659-19-012881-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 1,227,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_B737A429D7E9](/claim/clm_B737A429D7E9.md) | [clm_529E4815C0D2](/claim/clm_529E4815C0D2.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465920028557/0001104659-20-028557-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 3,144,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_F01EE117485C](/claim/clm_F01EE117485C.md) | [clm_B737A429D7E9](/claim/clm_B737A429D7E9.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465921022456/0001104659-21-022456-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 115,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_AE6BE83BCC88](/claim/clm_AE6BE83BCC88.md) | [clm_F01EE117485C](/claim/clm_F01EE117485C.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465922025720/0001104659-22-025720-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 3,293,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_9F87514064CD](/claim/clm_9F87514064CD.md) | [clm_AE6BE83BCC88](/claim/clm_AE6BE83BCC88.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465923023818/0001104659-23-023818-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 5,961,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_DCF412B5DDDA](/claim/clm_DCF412B5DDDA.md) | [clm_9F87514064CD](/claim/clm_9F87514064CD.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 7,041,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_7F0BFE9EB1CD](/claim/clm_7F0BFE9EB1CD.md) | [clm_DCF412B5DDDA](/claim/clm_DCF412B5DDDA.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465925014750/0001104659-25-014750-index.htm - [AstraZeneca](/record/astrazeneca.md) | net_income | 10,233,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_7F0BFE9EB1CD](/claim/clm_7F0BFE9EB1CD.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm ## What replaced what - $2.83 billion (2015-12-31 to 2016-12-31, [clm_DEF1603E885B](/claim/clm_DEF1603E885B.md)) was replaced by $3.41 billion from 2016-12-31 ([clm_194B34501880](/claim/clm_194B34501880.md)) - $3.41 billion (2016-12-31 to 2017-12-31, [clm_194B34501880](/claim/clm_194B34501880.md)) was replaced by $2.87 billion from 2017-12-31 ([clm_7BDCCD2AEF61](/claim/clm_7BDCCD2AEF61.md)) - $2.87 billion (2017-12-31 to 2018-12-31, [clm_7BDCCD2AEF61](/claim/clm_7BDCCD2AEF61.md)) was replaced by $2.05 billion from 2018-12-31 ([clm_80CF1A157103](/claim/clm_80CF1A157103.md)) - $2.05 billion (2018-12-31 to 2019-12-31, [clm_80CF1A157103](/claim/clm_80CF1A157103.md)) was replaced by $1.23 billion from 2019-12-31 ([clm_529E4815C0D2](/claim/clm_529E4815C0D2.md)) - $1.23 billion (2019-12-31 to 2020-12-31, [clm_529E4815C0D2](/claim/clm_529E4815C0D2.md)) was replaced by $3.14 billion from 2020-12-31 ([clm_B737A429D7E9](/claim/clm_B737A429D7E9.md)) - $3.14 billion (2020-12-31 to 2021-12-31, [clm_B737A429D7E9](/claim/clm_B737A429D7E9.md)) was replaced by $115 million from 2021-12-31 ([clm_F01EE117485C](/claim/clm_F01EE117485C.md)) - $115 million (2021-12-31 to 2022-12-31, [clm_F01EE117485C](/claim/clm_F01EE117485C.md)) was replaced by $3.29 billion from 2022-12-31 ([clm_AE6BE83BCC88](/claim/clm_AE6BE83BCC88.md)) - $3.29 billion (2022-12-31 to 2023-12-31, [clm_AE6BE83BCC88](/claim/clm_AE6BE83BCC88.md)) was replaced by $5.96 billion from 2023-12-31 ([clm_9F87514064CD](/claim/clm_9F87514064CD.md)) - $5.96 billion (2023-12-31 to 2024-12-31, [clm_9F87514064CD](/claim/clm_9F87514064CD.md)) was replaced by $7.04 billion from 2024-12-31 ([clm_DCF412B5DDDA](/claim/clm_DCF412B5DDDA.md)) - $7.04 billion (2024-12-31 to 2025-12-31, [clm_DCF412B5DDDA](/claim/clm_DCF412B5DDDA.md)) was replaced by $10.23 billion from 2025-12-31 ([clm_7F0BFE9EB1CD](/claim/clm_7F0BFE9EB1CD.md)) ## Questions this record answers ### What is AstraZeneca's current net income? $10.23 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 8, 2026 (status valid, confidence 0.95). ### When did AstraZeneca's net income last change? The latest value on the record is $10.23 billion, dated December 31, 2025; before it the record holds $7.04 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was AstraZeneca's net income before $10.23 billion? $7.04 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/astrazeneca/net_income (markdown: /record/astrazeneca/net_income.md) - Entity twin: /record/astrazeneca.md ยท timeline: /timelines/astrazeneca.md - Every company's net income: /facts/net_income.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.